Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting
Rhea-AI Summary
Stryker (NYSE: SYK) unveiled significant advancements in its Mako SmartRobotics™ technology at AAOS 2025 Annual Meeting in San Diego. The company highlighted that Mako has achieved over 1.5 million procedures globally across 45 countries.
Key announcements include:
- Introduction of Mako Total Hip with Advanced Primary and Revision, featuring first-to-market robotic hip revision capability
- Launch of fourth-generation Mako 4 system, offering multiple applications across Total Hip, Total Knee, Partial Knee and Spine procedures
- Integration of fourth-generation Q Guidance System
- Expansion into Mako Spine and Mako Shoulder applications
The company completed initial Mako Spine cases in October and plans full U.S. commercial launch in second half of 2025. Mako Shoulder, introduced late last year, remains in market release through 2025.
Positive
- Market leadership with 1.5 million Mako procedures performed globally across 45 countries
- First-to-market position in robotic hip revision capability
- Expansion of product portfolio with Mako 4 system supporting multiple applications
- Strategic entry into new markets with Spine and Shoulder applications
Negative
- market release status for both Spine and Shoulder applications through 2025
- Delayed full commercial launch of Mako Spine until second half of 2025
News Market Reaction – SYK
In the trading session that priced this news, SYK declined 1.30%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Latest technology offers more applications and innovation across more specialties
With the introduction of Mako Total Hip with Advanced Primary and Revision, Stryker expands on its established Mako Total Hip offering to include a first-to-market robotic hip revision capability. In revision total hip arthroplasty (THA), the expanded Mako Total Hip application is engineered to streamline workflow and enable confidence in challenging procedures with new features such as augment and screw planning, intraoperative screw trajectory guidance and compatibility with Stryker's revision hip implant portfolio. These new capabilities are designed to help surgeons simplify hip procedures by knowing more with Mako's 3D CT-based planning, now across both primary and revision THA procedures.
Additionally, now commercially available is Stryker's fourth generation Mako System, Mako 4, a single robotics system that delivers additional applications and innovation, designed to offer a premium clinical and operational experience compared to manual across Mako Total Hip, Total Knee, Partial Knee and Spine. Mako 4 also integrates Stryker's fourth-generation Q Guidance System, which is built on over 20 years of experience developing guidance technologies.
"Today's advancements in Mako SmartRobotics™ build on a foundation of clinical impact, innovation and market leadership," said Keith Evans, vice president and general manager of Stryker's Mako and Enabling Technologies business. "We are thrilled to showcase and demonstrate the future of Mako, not only what it can do but who it serves – more surgeons, more patients, across more specialties and more procedures."
Mako Spine and Mako Shoulder are the latest to join the SmartRobotics™ suite of applications. Stryker completed its first Mako Spine cases in October and continues its limited market release with full
AAOS 2025 Annual Meeting attendees can visit Stryker's booth (#2529) to learn more about Mako 4 and our new applications. Stryker will hold demonstrations, exhibitions and a symposium throughout the week. For more information, please visit – MakoMeansMore.com.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Media contact
Stryker, Joint Replacement
Niamh Grano
Sr. Communications Manager
niamh.grano@stryker.com
201.831.5589
View original content to download multimedia:https://www.prnewswire.com/news-releases/stryker-showcases-next-generation-of-mako-smartrobotics-at-aaos-2025-annual-meeting-302397425.html
SOURCE Stryker